Last reviewed · How we verify

NCT04628689

Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach With Different Concentrations Of Bupivacaine in Hip Surgeries

Status unknown Phase 4 Last updated 20 November 2020
What this trial tests

Phase 4 trial testing quadratus lumborum block by paraspinous sagittal shift approach in Hip Surgeries in 5 participants. Status unknown.

Timeline
20 November 2020
Primary endpoint
30 December 2020
30 December 2020

Quick facts

Lead sponsorBeni-Suef University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment5
Start date20 November 2020
Primary completion30 December 2020
Estimated completion30 December 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 30 to 60, any sex, with Hip Surgeries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the optimum concentration of bupivacaine in Paraspinous Sagittal Shift Approach for Quadratus Lumborum Block in hip Surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04628689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing